Global Pneumococcal Vaccine Competitive Landscape Professional Research Report 2025
Description
Global Pneumococcal Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
The pneumococcal vaccine is a preventive immunization designed to protect against infections caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is a major cause of serious respiratory illnesses, such as pneumonia, meningitis, and septicemia, particularly in young children, the elderly, and individuals with weakened immune systems. The pneumococcal vaccine stimulates the immune system to produce antibodies against specific strains of the bacterium, reducing the likelihood of infection and its potentially severe complications. There are different types of pneumococcal vaccines, including conjugate and polysaccharide vaccines, each targeting various age groups and offering protection against a range of pneumococcal strains. The vaccine is a vital component of routine immunization schedules globally, contributing significantly to the prevention of pneumococcal diseases and their associated morbidity and mortality.
According to DIResearch's in-depth investigation and research, the global Pneumococcal Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur, CDIBP etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Pneumococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pneumococcal Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pneumococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pneumococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Pneumococcal Vaccine Include:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Pneumococcal Vaccine Product Segment Include:
PPSV 23
PCV 7/13
PCV 10
Pneumococcal Vaccine Product Application Include:
Child
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Pneumococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Pneumococcal Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Pneumococcal Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Pneumococcal Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Pneumococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Pneumococcal Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Pneumococcal Vaccine Product by Type
- 1.2.1 PPSV 23
- 1.2.2 PCV 7/13
- 1.2.3 PCV 10
- 1.3 Pneumococcal Vaccine Product by Application
- 1.3.1 Child
- 1.3.2 Adult
- 1.4 Global Pneumococcal Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Pneumococcal Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Pneumococcal Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Pneumococcal Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Pneumococcal Vaccine Industry Trends and Innovation
- 1.5.1 Pneumococcal Vaccine Industry Trends and Innovation
- 1.5.2 Pneumococcal Vaccine Market Drivers and Challenges
- 2 Pneumococcal Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Pneumococcal Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Pneumococcal Vaccine Market Analysis by Regions
- 4.1 Pneumococcal Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Pneumococcal Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Pneumococcal Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Pneumococcal Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Pneumococcal Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Pneumococcal Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Pneumococcal Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Pneumococcal Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Pneumococcal Vaccine Market Size by Type and Application
- 5.1 Global Pneumococcal Vaccine Market Size by Type
- 5.1.1 Global Pneumococcal Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Pneumococcal Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Pneumococcal Vaccine Market Size by Application
- 5.2.1 Global Pneumococcal Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Pneumococcal Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Pneumococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Pneumococcal Vaccine Market Size by Type
- 6.3.1 North America Pneumococcal Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Pneumococcal Vaccine Revenue by Type (2020-2032)
- 6.4 North America Pneumococcal Vaccine Market Size by Application
- 6.4.1 North America Pneumococcal Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Pneumococcal Vaccine Revenue by Application (2020-2032)
- 6.5 North America Pneumococcal Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Pneumococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Pneumococcal Vaccine Market Size by Type
- 7.3.1 Europe Pneumococcal Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Pneumococcal Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Pneumococcal Vaccine Market Size by Application
- 7.4.1 Europe Pneumococcal Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Pneumococcal Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Pneumococcal Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Pneumococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Pneumococcal Vaccine Market Size by Type
- 8.3.1 China Pneumococcal Vaccine Sales by Type (2020-2032)
- 8.3.2 China Pneumococcal Vaccine Revenue by Type (2020-2032)
- 8.4 China Pneumococcal Vaccine Market Size by Application
- 8.4.1 China Pneumococcal Vaccine Sales by Application (2020-2032)
- 8.4.2 China Pneumococcal Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Pneumococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Pneumococcal Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Pneumococcal Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Pneumococcal Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Pneumococcal Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Pneumococcal Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Pneumococcal Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Pneumococcal Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Pneumococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Pneumococcal Vaccine Market Size by Type
- 10.3.1 Latin America Pneumococcal Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Pneumococcal Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Pneumococcal Vaccine Market Size by Application
- 10.4.1 Latin America Pneumococcal Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Pneumococcal Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Pneumococcal Vaccine Market Size by Country
- 10.6 Latin America Pneumococcal Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Pneumococcal Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Pneumococcal Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Pneumococcal Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Pneumococcal Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Pneumococcal Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Pneumococcal Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Pneumococcal Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Pneumococcal Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Pneumococcal Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Pneumococcal Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Pneumococcal Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Pneumococcal Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Pneumococcal Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Pneumococcal Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Pfizer
- 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Pfizer Pneumococcal Vaccine Product Portfolio
- 13.1.3 Pfizer Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 GSK
- 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 GSK Pneumococcal Vaccine Product Portfolio
- 13.2.3 GSK Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 MSD
- 13.3.1 MSD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 MSD Pneumococcal Vaccine Product Portfolio
- 13.3.3 MSD Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Sanofipasteur
- 13.4.1 Sanofipasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sanofipasteur Pneumococcal Vaccine Product Portfolio
- 13.4.3 Sanofipasteur Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 CDIBP
- 13.5.1 CDIBP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 CDIBP Pneumococcal Vaccine Product Portfolio
- 13.5.3 CDIBP Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Pneumococcal Vaccine Industry Chain Analysis
- 14.2 Pneumococcal Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Pneumococcal Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Pneumococcal Vaccine Typical Downstream Customers
- 14.4 Pneumococcal Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
